Home › NDC Lookup › RxCUI directory › RxCUI 248642

Fluoxetine 20 MG Oral Tablet — RxCUI 248642

RxNorm drug concept · Semantic clinical drug
RxCUI 248642 Semantic clinical drug · SCD ● Current RxNorm concept 25 FDA products 54 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI248642
Official nameFluoxetine 20 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asfluoxetine 20 MG (as fluoxetine hydrochloride 22.4 MG) Oral Tablet
FDA products mapped25
Package NDCs mapped54
Reported Medicaid activity (SDUD)375,607 prescriptions · 47 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Fluoxetine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Most people don't feel a noticeable difference right away — that's completely normal. It typically takes several weeks to start feeling the full benefit, and some people need a few...
  • How long does it take for fluoxetine to actually start working?
  • It's really important not to stop on your own, even if you feel great. Stopping suddenly can cause discontinuation symptoms, and your condition may come back. The good news is that...
  • Can I stop taking fluoxetine if I start feeling better?
📖 Read our full Fluoxetine guide →

🕸️ Concept Web — How Fluoxetine 20 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Fluoxetine 20 MG Oral Tablet RxCUI 248642

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Fluoxetine 4493
  2. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Fluoxetine Oral Tablet 372233
    • Fluoxetine Oral Product 1160836
    • Fluoxetine Pill 1160837
    • Oral Tablet 317541
    • Oral Product 1151131
    • Pill 1151133
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Fluoxetine 20 MG 315952

Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Fluoxetine 20 MG SCDC · 315952
  • Fluoxetine Oral Tablet SCDF · 372233
  • Fluoxetine Oral Product SCDG · 1160836
  • Fluoxetine Pill SCDG · 1160837

📦 FDA Products & Package NDCs

25 products · 54 package NDCs
54 package NDCs map to RxCUI 248642 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
84386-0104-01 100 TABLET, FILM COATED in 1 BOTTLE (84386-104-01) Fluoxetine Aurobindo Pharma Limited 2026-01-15
84386-0104-30 30 TABLET, FILM COATED in 1 BOTTLE (84386-104-30) Fluoxetine Aurobindo Pharma Limited 2026-01-15
84386-0105-01 100 TABLET, FILM COATED in 1 BOTTLE (84386-105-01) Fluoxetine Aurobindo Pharma Limited 2026-01-15
84386-0105-30 30 TABLET, FILM COATED in 1 BOTTLE (84386-105-30) Fluoxetine Aurobindo Pharma Limited 2026-01-15
Observed labelers: Aurobindo Pharma Limited (8) · Bryant Ranch Prepack (7) · Alembic Pharmaceuticals Inc. (6) · Alembic Pharmaceuticals Limited (6) · ScieGen Pharmaceuticals, Inc (6) · Strides Pharma Science Limited (5) · +5 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.